Current pharmacological interventions for hyperlipidemia include statins, fibrates, bile acid sequestrants, cholesterol absorption inhibitors, and proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors [16–19]. The gene discussed is PCSK9; the disease is hyperlipidemia.